BioNTech SE

22UA.F Q3 2025

Reported: 2025-11-04

BioNTech reported strong progress in Q3 2025, showcasing significant advancements in its oncology pipeline and maintaining robust financial health, with a cash position of over EUR 16 billion.

Key takeaways

Continued progress on Pumitamig's global registrational trials in lung cancer, with a Phase III breast cancer trial projected to initiate by year-end.
Successfully presented promising Phase II trial updates for BNT111 and Autogene cevumeran, reinforcing the potential of mRNA cancer immunotherapies in adjuvant settings.
Launched a variant-adapted COVID-19 vaccine, augmenting the company’s product portfolio while supporting ongoing oncology transition efforts.
Significant advancements in AI-driven therapeutic development were showcased during the company's second AI Day, underlining BioNTech's commitment to innovation.
Financially, the company remains strong, with total cash and equivalents exceeding EUR 16 billion, ensuring flexibility for future investments.

View recap

Adeia Inc. Common Stock

ADEA Q3 2025

Reported: 2025-11-04

Adeia's Q3 2025 results met expectations with revenue of $87.3 million, driven by strong growth in non-Pay TV recurring revenue, which rose 31% year-over-year. However, the company has adjusted its full-year revenue guidance amidst ongoing litigation and other strategic initiatives.

Key takeaways

Non-Pay TV recurring revenue increased by 31% year-over-year, showcasing robust demand across expanding markets.
The company filed patent infringement lawsuits against AMD, emphasizing its commitment to protecting intellectual property and ensuring appropriate value for innovations.
Revenue guidance for 2025 was revised down due to delays in closing a license agreement, with clearer paths to growth anticipated in 2026 from ongoing negotiations.
Two long-term licensing agreements were successfully closed, including a renewal with Altice, reinforcing Adeia's expansion into the broader e-commerce space.
Progress in litigation regarding Disney and other notable players is encouraging, maintaining optimism for favorable outcomes that could enhance value.

View recap

Archer-Daniels-Midland Company

ADM Q3 2025

Reported: 2025-11-04

ADM delivered a solid third quarter with adjusted earnings per share of $0.92 and strong cash flow, despite facing a challenging operating environment.

Key takeaways

Total segment operating profit reached $845 million, while cash flow from operations before working capital changes was $2.1 billion year-to-date.
Ag Services & Oilseeds reported a 2.6% increase in crush volumes, aided by a robust export program, despite lower margins.
Nutrition segment showed continuous improvement, with Flavors North America achieving record quarterly revenue and a new joint venture in Animal Nutrition planned for 2026.
The company aims to achieve $200 million to $300 million in cost savings in 2025 and overall savings of $500 million to $750 million over the next 3 to 5 years.
ADM's commitment to innovation is evident in its advancements in flavor systems and postbiotics, highlighting strong growth potential in key segments.

View recap

ADT Inc.

ADT Q3 2025

Reported: 2025-11-04

ADT reported strong third-quarter results with notable revenue growth and improved earnings per share, reflecting the company’s resilient business model and effective execution of its strategic initiatives.

Key takeaways

Total revenue increased by 4% year-over-year to $1.3 billion, while adjusted EBITDA grew by 3% to $676 million.
Adjusted earnings per diluted share rose 15% to $0.23, and adjusted free cash flow reached $709 million year-to-date.
Recurring monthly revenue increased 1% year-over-year to $362 million, despite a slight uptick in attrition to 13%.
Continued investments in the ADT+ platform are enhancing customer experience and driving adoption, with 25% of new customers utilizing the platform.
The company returned $746 million to shareholders through share repurchases and dividends, showcasing strong capital return strategies.

View recap

Armada Hoffler Properties, Inc.

AHH Q3 2025

Reported: 2025-11-04

Armada Hoffler delivered solid third-quarter results for 2025, exceeding normalized FFO expectations and achieving a portfolio occupancy of 96%. The company is focused on enhancing its balance sheet and positioning for sustainable growth.

Key takeaways

Normalized FFO reached $0.29 per diluted share, driven by consistent performance across all commercial asset classes.
Overall portfolio occupancy averaged an impressive 96%, with strong metrics in office (96.5%), retail (96%), and multifamily (94.2%).
Retail portfolio exhibited strong fundamentals with renewal spreads averaging 6.5% on a cash basis and significant foot traffic increases of 13% in high-traffic centers.
The company is narrowing 2025 FFO guidance to $1.03 - $1.07 per diluted share, reflecting its strategic shift towards higher-quality recurring property level earnings.
Armada Hoffler continues to strategically recycle capital and optimize property-level performance for long-term shareholder value creation.

View recap

Aker ASA

AKER.OL Q3 2025

Reported: 2025-11-04

Aker's strategic focus on simplifying its portfolio and investing in growth areas has led to a substantial increase in net asset value and share price, highlighting strong operational performance across its businesses.

Key takeaways

Net asset value rose to NOK 67.5 billion, with a share price increase of nearly 20% this quarter, significantly outperforming the Oslo Stock Exchange Benchmark Index.
Year-to-date total shareholder return reached nearly 50%, supported by a second dividend payout of NOK 26.5 per share, totaling NOK 53 per share for the year.
Significant progress in AI infrastructure with the launch of Aker Nscale joint venture and a landmark $6.2 billion contract with Microsoft for renewable energy-powered data centers.
Aker BP exceeded production guidance and made a significant discovery, further bolstering operational performance in the energy sector.
Cognite showed impressive growth with Q3 SaaS bookings up 425% year-over-year, underscoring successful commercial development across various industries.

View recap

Ameresco, Inc.

AMRC Q3 2025

Reported: 2025-11-04

Ameresco delivered robust financial growth in Q3 2025, driven by strong demand for energy infrastructure solutions across various sectors, enhancing their project backlog and market position.

Key takeaways

Project backlog saw significant growth with energy infrastructure projects accounting for nearly 50% of total backlog.
Successful contracts include a 40-megawatt firm power plant for Hawaiian Electric and a 50-megawatt battery energy storage system with Nucor.
New opportunities are emerging in diverse sectors, including industrials and data centers, led by an escalating demand for resilient energy solutions.
Firm generation assets represent 22% of total assets in development, with battery storage systems now comprising 41%, showcasing the company’s agility in capitalizing on market trends.
Ameresco’s flexible business model, combining project delivery and long-term support, enhances competitive positioning in the evolving energy landscape.

View recap

Apollo Global Management, Inc.

APO Q3 2025

Reported: 2025-11-04

Apollo Global Management delivered strong third quarter results, with adjusted net income rising 17% year-over-year to $1.4 billion, driven by robust origination and inflows.

Key takeaways

Record fee-related earnings (FRE) of $652 million, up 23% year-over-year, reflecting strong management fee growth of 22%.
Total assets under management (AUM) reached a record $908 billion, a 24% increase from the prior year, supported by $82 billion in inflows during the quarter.
Anticipated strong performance in Q4 with estimated spread-related earnings (SRE) of approximately $880 million, resulting in estimated full-year SRE growth of 8%.
Ongoing demand for private assets across various markets, bolstered by strong fundamentals in infrastructure, retirement solutions, and the private asset sector.
The company continues to capitalize on multiple secular trends enhancing its growth potential in the asset management industry.

View recap

Biodesix, Inc.

BDSX Q3 2025

Reported: 2025-11-04

Biodesix reported strong third-quarter results for 2025, achieving a 20% increase in revenue and improved gross margins, while laying the groundwork for future growth in personalized diagnostics.

Key takeaways

Revenue growth accelerated to 20% year-over-year, indicating robust demand for diagnostic tests.
Gross margins improved by 400 basis points to 81%, reflecting operational effectiveness.
Adjusted EBITDA enhanced by 18%, signaling progress towards profitability in Q4.
Tests ordered from primary care surged 75% YOY, as the company expands its market strategy to enhance lung cancer diagnostics.
Average revenue per test increased by 7% from Q2, supported by successful market access initiatives.

View recap

Hugo Boss AG

BOSS.DE Q3 2025

Reported: 2025-11-04

HUGO BOSS reported a resilient Q3 2025 performance with stable EBIT and improvements in gross margins despite a slight decline in sales due to unfavorable wholesale delivery timing and currency headwinds.

Key takeaways

Group sales decreased 1% year-over-year, primarily impacted by unfavorable wholesale delivery timing and a weaker U.S. dollar.
EBIT remained stable at EUR 95 million, with a 30 basis point improvement in EBIT margin to 9.6% driven by structural efficiency gains.
Gross margin reached 61.2%, up 100 basis points, reflecting efficiency in sourcing and cost reduction measures.
BOSS Menswear sales remained stable, while strategic initiatives for BOSS Womenswear and HUGO continue to position the brands for long-term value.
Digital sales grew by 2%, supported by improved performance on hugoboss.com and partnerships, while brick-and-mortar retail showed recovery in conversion rates despite lower traffic.

View recap

Black Stone Minerals, L.P.

BSM Q3 2025

Reported: 2025-11-04

Black Stone Minerals reported a strong third quarter, demonstrating solid production growth and robust financial results, driven largely by its Permian assets and new development agreements in the Shelby Trough.

Key takeaways

Mineral and royalty production increased 5% quarter-over-quarter to 34,700 BOE per day, with total production at 36,300 BOE per day.
Net income reached $91.7 million, and distributable cash flow of $76.8 million represents a coverage ratio of 1.21x, supporting the $0.30 per unit distribution.
Ongoing development agreements in the Shelby Trough are expected to double the annual drilling rate in the next five years, fostering long-term growth potential.
The company completed $20 million in mineral and royalty acquisitions, bringing total acquisitions to approximately $193 million since September 2023.
Black Stone is well-positioned to capitalize on increasing LNG demand and favorable market dynamics in natural gas over the coming decade.

View recap

BWX Technologies, Inc.

BWXT Q3 2025

Reported: 2025-11-04

BWX Technologies reported a robust third quarter for 2025, achieving 12% organic revenue growth and strong profitability driven by increased demand in government and commercial operations.

Key takeaways

Revenue reached $866 million, with adjusted EBITDA growing by approximately 20%.
Book-to-bill ratio of 2.6, leading to a record backlog of $7.4 billion, up 23% sequentially and 119% year-over-year.
Significant contracts awarded include a $1.5 billion uranium enrichment initiative and a $1.6 billion supply contract for high-purity depleted uranium, highlighting government market strength.
Commercial operations revenue surged 122%, bolstered by acquisitions and growth in medical isotopes and nuclear power sectors.
Strong outlook for 2026, with expectations to exceed medium-term financial targets, driven by operational excellence and expansion in key markets.

View recap

CompoSecure Inc. Class A Common Stock

CMPO Q3 2025

Reported: 2025-11-04

CompoSecure experienced robust growth in Q3 2025, with net sales rising 13% year-over-year to $120.9 million and significant improvements in EBITDA margins, reflecting effective operational execution and strategic alignment.

Key takeaways

Net sales increased to $120.9 million, up 13% year-over-year, propelled by strategic initiatives and operational focus.
Pro forma adjusted EBITDA rose 30% to $47.7 million, achieving an EBITDA margin of 39.5%.
The planned business combination with Husky Technologies is expected to enhance growth opportunities and operational efficiencies.
Leadership changes include the transition to new CFO Mary Holt, bringing valuable experience from major corporations to support future growth.
Continued execution of the CompoSecure Operating System is driving significant improvements in profitability and organizational discipline.

View recap

Costamare Inc.

CMRE Q3 2025

Reported: 2025-11-04

Costamare delivered strong financial results in Q3 2025, achieving net income of approximately $99 million while successfully navigating a robust charter market despite geopolitical uncertainties.

Key takeaways

Adjusted net income rose to $98 million ($0.81 per share), reflecting solid performance and contracting strategy.
The fleet deployment remains strong, with 100% of revenue days fixed for 2025 and 80% for 2026, contributing to total contracted revenues of $2.6 billion.
Increased chartering activities and newbuild contracts, including an order for two additional 3,100 TEU containerships, secured an additional $310 million in revenues.
The idle fleet is critically low at less than 1%, ensuring a tight charter market with healthy rates.
Neptune Maritime Leasing continues to expand, having committed over $650 million across 50 shipping assets, enhancing diversified revenue streams.

View recap

Castle Biosciences, Inc.

CSTL Q3 2025

Reported: 2025-11-04

Castle Biosciences reported a pivotal quarter highlighted by the launch of AdvanceAD-Tx, a first-in-class gene expression test aimed at improving treatment outcomes for patients with moderate to severe atopic dermatitis.

Key takeaways

Successfully launched AdvanceAD-Tx, targeting a $33 billion market opportunity in the U.S. for moderate to severe atopic dermatitis.
Clinical validation shows AdvanceAD-Tx can significantly improve treatment response rates for patients on JAK inhibitors versus traditional therapies.
Approximately 80% of surveyed clinicians indicated intent to use AdvanceAD-Tx, underscoring strong market receptivity.
The company plans to explore multiple reimbursement pathways to facilitate patient access and drive early adoption of the test.

View recap

EverQuote, Inc.

EVER Q3 2025

Reported: 2025-11-04

EverQuote delivered record revenue and profit in Q3 2025, driven by increased enterprise carrier spending and the successful launch of enhanced AI-driven products.

Key takeaways

Total revenue rose 20% YoY to $173.9 million, with enterprise carrier spend up over 27%.
Adjusted EBITDA reached a record $25.1 million, reflecting a 33% increase YoY and a 14.4% adjusted EBITDA margin.
Smart Campaigns 3.0 launched, improving ad spend efficiency by 7% and enhancing client retention.
Over 35% of local agents now utilize multiple products, indicating strong cross-sell potential.
Targeting $1 billion in annual revenue by 2027 as part of a strategic transition to a multi-product, AI-powered growth solutions provider.

View recap

Eve Holding, Inc.

EVEX Q3 2025

Reported: 2025-11-04

Eve Holding, Inc. reported a strong Q3 2025, marked by significant advancements in their aircraft development and a growing order backlog of $14 billion.

Key takeaways

Completed installation and integration of all electrical motors in the engineering prototype, with first flight expected by early 2026.
Secured a contract with Embraer for landing gear, enhancing aircraft efficiency during ground operations.
Established agreements in the Middle East, positioning Bahrain as a regional hub for eVTOL adoption and paving the way for future test flights.
Pre-order backlog now totals approximately 2,800 aircraft, translating to nearly $14 billion in projected revenue.
Iron Bird functional testing has logged over 10,000 hours, facilitating streamlined certification and development processes.

View recap

Evonik Industries AG

EVK.DE Q3 2025

Reported: 2025-11-04

Evonik Industries experienced a challenging Q3 2025, prompting a reduction in full-year EBITDA guidance to EUR 1.9 billion, despite expectations for improved performance in Q4 due to sales recoveries in key segments.

Key takeaways

Q3 EBITDA was notably weaker, primarily due to cautious customer behavior and ongoing market headwinds.
The company anticipates a recovery in Q4, driven by a year-end sales surge in the Health Care segment and increased capacity in Animal Nutrition.
Free cash flow showed positive progress, with approximately EUR 300 million generated in Q3, bolstering confidence in achieving cash conversion guidance of 30% to 40%.
Significant workforce reductions of over 740 employees were implemented, aimed at streamlining operations and supporting long-term strategy amidst a tough market landscape.

View recap

Exact Sciences Corporation

EXAS Q3 2025

Reported: 2025-11-04

Exact Sciences reported a record third quarter in 2025, with revenue increasing 20% year-over-year to $851 million, driven by robust performance in its Cologuard product line and the successful launch of Cancerguard.

Key takeaways

Total revenue reached $851 million, surpassing guidance by $43 million, with screening revenue increasing 22% to $666 million.
Adjusted EBITDA rose 37% to $135 million, with margins expanding to 16%.
Free cash flow doubled to $190 million, highlighting improved collections and working capital management.
Full-year revenue guidance raised to $3.22–$3.235 billion, reflecting strong momentum in the core business.
Cologuard Plus demonstrated significant improvements in sensitivity and specificity, enhancing its market positioning amid expanded payer coverage.

View recap

Exelon Corporation

EXC Q3 2025

Reported: 2025-11-04

Exelon reported a robust Q3 with earnings per share of $0.86, surpassing expectations thanks to favorable weather conditions and effective operational strategies. The company reaffirmed its 2025 guidance, projecting operating earnings between $2.64 and $2.74 per share.

Key takeaways

Exelon's utility operations ranked 1st, 2nd, 4th, and 7th in reliability among peers, reflecting significant operational excellence.
The company is on track with rate cases, supporting investments that promise enhanced reliability and customer value.
Legislative progress in Illinois promotes energy efficiency initiatives and resource adequacy, positioning Exelon for future growth.
Strong demand signals are evident, with a large load pipeline exceeding 19 gigawatts and 27 gigawatts in progression toward connection agreements.
Anticipated transmission investments are expected to drive earnings growth at an annualized rate of 5% to 7% through 2028.

View recap

TIS Inc.

FTS.TO Q3 2025

Reported: 2025-11-04

Fortis Inc. reported solid third-quarter results with adjusted earnings per share of $0.87 and unveiled a new $28.8 billion 5-year capital plan focused entirely on regulated assets. The company continues to emphasize customer affordability while driving significant rate base growth.

Key takeaways

Adjusted EPS for Q3 2025 reached $0.87, highlighting strong financial performance.
Complete transition to 100% regulated assets following the sale of FortisTCI and operations in Belize.
New 5-year capital plan of $28.8 billion includes a ~$2.8 billion increase, targeting 7% annual rate base growth.
Dividend increased by ~4%, with annual growth guidance of 4% to 6% through 2030.
Capital investments are predominantly allocated (77%) to low-risk transmission and distribution projects.

View recap

Great Lakes Dredge & Dock Corporation

GLDD Q3 2025

Reported: 2025-11-04

Great Lakes Dredge & Dock Corp reported strong Q3 2025 results, with revenues increasing to $195.2 million and improved margins driven by high utilization of projects. The company’s dredging backlog remains robust at $935 million, signaling continued operational momentum.

Key takeaways

Revenues rose to $195.2 million, a $4 million increase year-over-year, supported by active project execution and the new dredge, Amelia Island.
Adjusted EBITDA improved to $39.3 million, reflecting a 20.1% margin, driven by strong project performance in capital and coastal protection projects.
The company secured $136 million in new project awards during the quarter, enhancing revenue visibility and backlog quality for 2026.
Completed the upsizing of the revolving credit facility to $430 million, extending maturity to 2030, and fully repaid $100 million in second-lien notes, reducing annual interest expense by nearly $6 million.
Net income increased to $17.7 million, significantly up from $8.9 million in the prior year, signaling improved profitability amidst effective cost management.

View recap

Gladstone Commercial Corporation

GOOD Q3 2025

Reported: 2025-11-04

Gladstone Commercial Corporation demonstrated strong operational stability in Q3 2025, bolstering its industrial concentration and maintaining high occupancy levels, despite facing challenging market conditions.

Key takeaways

Achieved 99.1% portfolio occupancy—the highest since Q1 2019—with a weighted average lease term (WALT) of 7.5 years.
Successfully acquired a $54.5 million industrial manufacturing portfolio, increasing industrial assets to 69% of annualized straight-line rents.
Recorded 100% rent collection rate, with same-store lease revenues up 3.1% year-over-year.
Increased credit facility to $600 million, enhancing financial flexibility for future acquisitions and portfolio improvements.
FFO and core FFO for Q3 2025 were $0.35 per share, consistent with Q3 2024 despite external market pressures.

View recap

Grab Holdings Limited Class A Ordinary Shares

GRAB Q3 2025

Reported: 2025-11-04

Grab achieved a strong performance in Q3 2025, with a notable 51% year-on-year increase in adjusted EBITDA, driven by a significant rise in monthly transacting users and continued cost discipline.

Key takeaways

Monthly transacting users increased by nearly 6 million year-over-year, reaching a total of 48 million.
On-demand GMV grew by 24% year-on-year; 20% on a constant currency basis.
Adjusted EBITDA rose to $136 million, marking the 15th consecutive quarter of profitability improvement.
Adjusted free cash flow improved by $185 million year-on-year to $283 million on a trailing 12-month basis.
Full-year EBITDA guidance has been increased to between $490 million and $500 million as the company anticipates sustained momentum across its business segments.

View recap

The Goodyear Tire & Rubber Company

GT Q3 2025

Reported: 2025-11-04

Goodyear reported strong third-quarter 2025 results with revenues of $4.6 billion and segment operating income of $287 million, slightly exceeding expectations despite a challenging market environment.

Key takeaways

Achieved sequential earnings and margin expansion through effective execution of Goodyear Forward initiatives.
Divested its Chemicals business, enhancing balance sheet health and focus on core profitability.
Launched three new premium all-terrain product lines and revitalized existing high-performance tire offerings, yielding strong consumer feedback.
EMEA operations returned to profitability, benefitting from 20% growth in consumer OE volume and successful factory restructurings.
Plans to expand brick-and-mortar retail footprint to strengthen market position and capitalize on rising service revenues.

View recap

ZoomInfo Technologies Inc.

GTM Q3 2025

Reported: 2025-11-04

ZoomInfo reported robust third-quarter 2025 results, achieving record revenue of $318 million, a 5% year-over-year increase, while successfully expanding its innovative AI-driven product portfolio.

Key takeaways

Adjusted operating income reached $118 million, marking a 37% margin and exceeding the high end of guidance.
Improved net revenue retention for the fifth consecutive quarter highlights ongoing customer loyalty and successful upmarket growth.
The operations suite grew over 20% year-over-year, underscoring the critical role of proprietary data in driving AI initiatives across go-to-market strategies.
ZoomInfo secured significant upmarket deals with major clients like Ryder System and Circle K, reinforcing its competitive positioning in multiple industries.
Launched new integrations with Salesforce that enhance B2B sales data accessibility, driving improved outcomes across client sales teams.

View recap

Halozyme Therapeutics, Inc.

HALO Q3 2025

Reported: 2025-11-04

Halozyme achieved record royalty revenues of $236 million in Q3 2025, a 52% year-over-year increase, contributing to total revenue growth of 22% to $354 million, driven by strong performance in its blockbuster subcutaneous therapies.

Key takeaways

Adjusted EBITDA surged 35% to $248 million, showcasing robust operational efficiency in a royalty-based model.
The company raised its full-year 2025 revenue guidance to $1.3-$1.375 billion, reflecting expected royalty revenue growth of 49%-54%.
Significant regulatory milestones included approvals for DARZALEX in new indications and expand the patient base for ENHANZE-enhanced therapies.
The recent acquisition of Elektrofi positions Halozyme to broaden its drug delivery technology portfolio and facilitate at-home administration options.

View recap

Hims & Hers Health, Inc.

HIMS Q3 2025

Reported: 2025-11-04

Hims & Hers reported a robust Q3 2025, achieving nearly 50% year-over-year revenue growth driven by a 50% increase in subscribers using personalized health solutions, bolstered by strategic partnerships and innovations.

Key takeaways

Subscribers utilizing personalized care solutions surged 50% year-over-year, underpinning revenue growth.
Strategic partnerships with Novo Nordisk and Marius Pharmaceuticals aim to expand access to innovative treatments, including Wegovy.
The company made a significant investment in GRAIL, enhancing its offerings in multi-cancer early detection.
A strategic reduction in GLP-1 treatment prices by up to 20% aims to broaden care accessibility.
Ongoing verticalization of compounding operations is expected to improve efficiency and quality in service delivery.

View recap

Hertz Global Holdings Inc Common Stock

HTZ Q3 2025

Reported: 2025-11-04

Hertz Global Holdings reported strong third-quarter results with $2.5 billion in revenue and adjusted EBITDA of $190 million, marking continued operational improvements and a return to profitability.

Key takeaways

Record utilization rates achieved, with a younger fleet now averaging under 12 months old, enhancing strategic asset management.
Positive EPS for the first time in two years, reflecting successful cost controls and operational efficiencies.
Significant growth in Net Promoter Score, up nearly 50% year-over-year in North America, highlighting improved customer satisfaction.
Ongoing transformation of Hertz car sales into a profit center, with a successful rent-to-buy program achieving a 70% purchase conversion rate.
Strategic collaboration with Cox Automotive advancing digital retail channels, enhancing customer experience in vehicle purchasing.

View recap

IAC/InterActiveCorp

IAC Q3 2025

Reported: 2025-11-04

IAC's third-quarter results demonstrate resilience amidst strategic changes, highlighting robust performance in its People Inc. division and continued focus on capitalizing opportunities within MGM.

Key takeaways

People Inc. shows strong outperformance in digital publishing, transitioning successfully to modern content strategies amidst industry challenges.
MGM's recovery post-pandemic continues, with significant share repurchases and growing digital profitability.
IAC plans to divest non-core assets and streamline operations, reinforcing its commitment to enhancing shareholder value.
The company emphasizes an innovative approach to content monetization, aiming to transform traditional publishing strategies.
Management expresses confidence in overcoming external market pressures, positioning IAC for future growth.

View recap

Ichor Holdings, Ltd.

ICHR Q3 2025

Reported: 2025-11-04

Ichor reported Q3 2025 revenues of $239 million, exceeding expectations amid strong demand in etch and deposition markets, although declining orders in non-semi sectors impacted gross margins.

Key takeaways

Revenues increased 13% year-over-year, driven by gains from leading-edge semiconductor customers.
Gross margin narrowed to 12.1%, impacted by lower order rates from the IMG non-semi business, resulting in a 1 percentage point decline.
Restructuring costs of $18.3 million were recognized, linked to the consolidation of operations and potential for additional charges ahead.
New CEO Phil Barros emphasizes operational efficiency and development of proprietary components to navigate current market challenges.
Outlook for Q4 reflects expected continued weakness in specific end markets, with operational focus on aligning manufacturing capacity to targeted margins.

View recap

Gartner, Inc.

IT Q3 2025

Reported: 2025-11-04

Gartner delivered stronger-than-expected financial results in Q3 2025, with solid client retention and significant stock repurchases, positioning the company for sustained long-term growth amid a dynamic macroeconomic environment.

Key takeaways

Adjusted EBITDA surpassed expectations, reflecting effective operational adaptations and ongoing client value delivery.
Contract value grew 3% year-over-year, with a 6% increase when excluding U.S. federal government contracts.
Client retention improved, alongside higher engagement levels, signaling a positive trajectory for future renewals.
The company repurchased over $1 billion in stock, reducing the share count by 6% year-over-year.
Strong demand for AI insights is driving increased productivity, with a 31% rise in content published per analyst year-over-year.

View recap

Kosmos Energy Ltd.

KOS Q3 2025

Reported: 2025-11-04

Kosmos Energy delivered strong third-quarter results, with production nearing record highs and a significant reduction in capital expenditures, emphasizing their commitment to free cash flow and balance sheet resilience.

Key takeaways

Gross production at Jubilee increased by 13% quarter-on-quarter to approximately 62,500 barrels of oil per day, aided by new well contributions.
Capital expenditures are now expected to fall below $350 million for the year, down $500 million year-on-year, reflecting improved cost efficiency.
The company’s overall net production rose to around 31,300 barrels of oil equivalent per day, with a notable 60% increase in third-quarter production from the GTA project.
Successful refinancing of debt maturities and strengthened liquidity position, supported by a $250 million term loan from Shell, enhances financial stability.
Continued focus on operational improvements with targeting of reduced overhead and operational costs across projects to drive future profitability.

View recap

Lattice Semiconductor Corporation

LSCC Q3 2025

Reported: 2025-11-04

Lattice Semiconductor reported robust third-quarter results, achieving $133.3 million in revenue, reflecting 7.6% sequential growth and a strong outlook for continued expansion into Q4 and beyond.

Key takeaways

Q3 revenue growth of 7.6% sequentially and 4.9% year-over-year, marking the highest growth in over four years.
Key segments, such as communications and computing, experienced significant increases, with sales up 21% year-over-year, driven by AI infrastructure investments.
Q4 revenue guidance projected at $143 million, equating to a 22% year-on-year growth expectation, signaling strong recovery momentum.
Continued strategic inventory normalization in the Industrial and Automotive segments positions Lattice for renewed growth into 2026.
Accelerating adoption of post-quantum cryptography solutions and expanded AI usage are further bolstering Lattice’s market opportunities.

View recap

Marriott International, Inc.

MAR Q3 2025

Reported: 2025-11-04

Marriott International reported better-than-expected Q3 results, fueled by robust global development and strong performance in the luxury segment, despite modest overall RevPAR growth amid macroeconomic uncertainties.

Key takeaways

Global RevPAR increased 0.5%, with international RevPAR up 2.6%, while the U.S. & Canada saw a slight decline of 0.4%.
The company expanded its global portfolio by 4.7% year-over-year, reaching over 1.75 million rooms, with nearly 596,000 rooms in the pipeline.
Luxury segment RevPAR rose 4%, driven by resilient high-end consumer demand, contrasting with weaker performance in select service brands.
Marriott Bonvoy membership grew to nearly 260 million, a significant 18% increase year-over-year, enhancing guest engagement and loyalty.
RevPAR is projected to accelerate with expected growth of 1% to 2% in Q4, indicating a positive outlook for full-year performance.

View recap

Medifast, Inc.

MED Q3 2025

Reported: 2025-11-04

Medifast's third-quarter results for 2025 showcased a strategic shift towards a holistic approach to metabolic health, reinforcing its commitment to long-term wellness solutions while navigating changes in the weight loss industry.

Key takeaways

Achieved 16-week clinical results showing clients retained 98% of lean mass and reduced visceral fat by 14%, underscoring the effectiveness of its metabolic health programs.
Expanded insights with 61% of coaches assisting clients using GLP-1 medications, highlighting the integration of medication knowledge into client support.
Announced plans for innovative product launches incorporating next-generation ingredients targeting metabolic enhancement, set to hit the market next year.
Transitioning brand perception from a weight loss company to a broader leader in metabolic health, targeting a more expansive and durable market.

View recap

AG Mortgage Investment Trust, Inc.

MITT Q3 2025

Reported: 2025-11-04

AG Mortgage Investment Trust (MITT) reported a robust third quarter for 2025, highlighted by strong earnings growth and an increase in book value, despite strategic dilution from an acquisition.

Key takeaways

Book value rose to $10.46 per share, reflecting a 0.7% increase even after a 1.8% dilution from acquiring an additional 21.4% interest in Arc Home.
Earnings available for distribution (EAD) increased to $0.23 per share, supported by robust performance from the investment portfolio and Arc Home's contributions.
Successfully monetized $66 million in legacy WMC assets, allowing for a 20% expansion of the investment portfolio through residential mortgage acquisitions.
The company executed four securitizations, significantly financing its acquisitions while mitigating risk.
GAAP net income was reported at $14.6 million, or $0.47 per share, driven by strong asset appreciation in residential mortgage loans and non-Agency RMBS.

View recap

MPLX LP

MPLX Q3 2025

Reported: 2025-11-04

MPLX achieved robust third-quarter results, increasing adjusted EBITDA by 4% year-to-date to $5.2 billion, while also raising its quarterly distribution by 12.5%. The company continues to pursue strategic growth initiatives, particularly in the Permian and Marcellus Basins.

Key takeaways

Adjusted EBITDA for Q3 reached $1.8 billion, contributing to a year-to-date total of $5.2 billion.
Distributable cash flows amounted to $1.5 billion, enabling $1.1 billion return to unitholders.
Completed two strategic acquisitions, enhancing MPLX's competitive position in NGL and gas treating operations.
Positioned for mid-single-digit adjusted EBITDA growth, with significant investments in natural gas and NGL services.
Advancements in pipeline projects and infrastructure expected to drive long-term value and market access in key regions.

View recap

PLAYSTUDIOS Inc. Class A Common Stock

MYPS Q3 2025

Reported: 2025-11-04

PLAYSTUDIOS reported its Q3 2025 earnings amid ongoing category challenges, demonstrating resilience through strategic reinvestments in core growth initiatives while navigating market headwinds.

Key takeaways

Direct-to-consumer revenue surged 48% quarter-over-quarter to $7.7 million, reflecting strong growth post-Apple policy changes.
The company's new sweepstakes product, Win Zone, is gaining traction with improved engagement metrics and a total addressable market estimated at $3.5-$4 billion despite regulatory pressures.
Tetris Block Party is in open beta, showing promising early performance and signaling potential for broader market success in 2026.
Strategic focus remains on enhancing player value and service, with a renewed commitment to quality over aggressive monetization tactics.
Adoption of AI in game development is expected to streamline processes and improve operational efficiency going forward.

View recap

National Retail Properties, Inc.

NNN Q3 2025

Reported: 2025-11-04

NNN REIT reported strong third-quarter results, with a core FFO of $0.85 per share and a strategic increase in acquisitions, underpinning their commitment to shareholder value and long-term growth.

Key takeaways

Closed 20 deals totaling 57 assets for $283 million, raising the 2025 acquisition target to $900 million, a record for the company.
Core FFO per share increased by 1.2% year-over-year, reflecting operational efficiency and robust asset performance.
Occupancy decreased to 97.5% due to a legal dispute with a tenant, yet management expects to exceed 98% occupancy by year-end through proactive asset resolutions.
Annualized base rent rose to $912 million, marking over a 7% increase year-over-year, with notable rental rate renewals averaging 108% above previous rents.
Strong balance sheet with $1.4 billion in total availability and an industry-leading average debt maturity of nearly 11 years, positioning NNN for continued growth.

View recap

Nuvation Bio Inc.

NUVB Q3 2025

Reported: 2025-11-04

Nuvation Bio reported strong momentum in its first full quarter post-IBTROZI FDA approval, with 204 new patient starts and continued positive feedback from the medical community regarding its efficacy and safety profile.

Key takeaways

IBTROZI achieved 204 new patient starts during Q3 2025, averaging over 15 per week, indicating robust market acceptance.
The median duration of response for TKI-naive patients has increased to 50 months, supporting the drug's competitive positioning as a potential new standard of care.
Recent clinical data showcased an impressive 66% intracranial response rate in patients with brain metastases, highlighting IBTROZI's unique efficacy in a critical patient subgroup.
Nuvation Bio plans to submit a supplemental NDA for a label update based on the latest data, aiming to enhance product positioning further.
The company continues to differentiate IBTROZI from competitors by emphasizing its safety and efficacy in real-world clinical settings.

View recap

Navitas Semiconductor Corporation Common Stock

NVTS Q3 2025

Reported: 2025-11-04

Navitas Semiconductor's Q3 2025 results highlight a strong strategic pivot towards high-power markets, positioning the company for significant growth in AI data centers and energy infrastructure.

Key takeaways

Leadership change aims to transform Navitas into a focused high-power technology provider, referred to as "Navitas 2.0."
Significant demand for GaN and high-voltage SiC technologies is anticipated, driven by electrification trends in AI and energy sectors.
Over 300 million GaN units shipped demonstrate strong market presence and reliability, with further growth expected from emerging applications.
Partnerships with leading fabs and a robust patent portfolio enhance competitive positioning in evolving power architecture markets.
The overall market for high-power applications is continuing to expand, offering long-term opportunities for sustainable revenue growth.

View recap

Realty Income Corporation

O Q3 2025

Reported: 2025-11-04

Realty Income demonstrated strong growth in Q3 2025, investing $1.4 billion globally while increasing total year-to-date investment volume to over $3.9 billion, surpassing all of 2024.

Key takeaways

Achieved a weighted average initial cash yield of 7.7% on $1.4 billion in investments for the quarter, with a total sourcing volume of $31 billion.
Portfolio occupancy improved to 98.7%, with a rent recapture rate of 103.5%, reflecting strong tenant renewals.
European investments accounted for 72% of quarterly volume, highlighting the advantageous risk-adjusted opportunities in that market compared to the U.S.
Enhanced liquidity through the launch of a perpetual life fund aimed at supporting growth objectives.
Lease termination income recognized at $27.3 million, illustrating effective asset management strategies.

View recap

Offerpad Solutions Inc. Class A Common Stock

OPAD Q3 2025

Reported: 2025-11-04

Offerpad reported third-quarter 2025 revenues of $133 million, with a focus on operational efficiency amid a transitioning housing market, resulting in improved gross margins and notable reductions in operating expenses.

Key takeaways

Sold 367 homes with a gross margin of 7%, yielding a gross profit of $9.3 million.
Achieved a 37% year-over-year reduction in operating expenses, totaling approximately $12 million, through enhanced efficiency measures.
Introduced AI-driven technologies to improve property assessment and pricing accuracy, reinforcing competitive positioning.
Strengthened leadership with the appointment of Chris Carpenter as Chief Operating Officer to enhance operational execution and scalability.
Set a near-term goal of 1,000 transactions per quarter, reflecting a strategic focus on controlled growth in acquisition volumes.

View recap

Paymentus Holdings, Inc.

PAY Q3 2025

Reported: 2025-11-04

Paymentus delivered impressive Q3 2025 results with revenue growth of 34.2% year-over-year and a record adjusted EBITDA margin of 36.5%, driven by strategic client onboarding and expanding enterprise engagements.

Key takeaways

Revenue reached $310.7 million, fueled by increased biller counts and higher transaction values.
Contribution profit rose to $98.3 million, reflecting a 22.8% year-over-year increase.
Achieved a record adjusted EBITDA of $35.9 million, representing a 45.9% increase and exceeding the Rule of 40 at 59%.
Significant momentum in bookings, particularly in the large enterprise segment, with a diverse client base across multiple verticals.
Positive trajectory for long-term growth, as the company capitalizes on a robust market opportunity and ongoing investments in platform capabilities.

View recap

The Progressive Corporation

PGR Q3 2025

Reported: 2025-11-04

Progressive delivered a strong Q3 2025 with an impressive 89.5 combined ratio and continued premium growth of 10%, underscoring its competitive position in the market despite an evolving regulatory landscape in Florida.

Key takeaways

Achieved a combined ratio of 89.5, indicating robust operational efficiency and underwriting performance.
Year-to-date premium growth reached 13%, with policies in force increasing by 12%, translating to 4.2 million additional policyholders.
Recognized a $950 million policyholder credit expense in Florida, influenced by recent legislative changes that have improved loss cost metrics.
Comprehensive income for the year stood at $10 billion, a notable increase of over 30% compared to 2024.
Trailing 12-month return on equity hit 37.1%, reflecting strong profitability and capital management.

View recap

Koninklijke Philips N.V.

PHIA.AS Q3 2025

Reported: 2025-11-04

Royal Philips reported a strong Q3 2025, driven by an 8% growth in order intake and robust performance across all business segments, particularly Personal Health. The company's adjusted EBITDA margin expanded despite ongoing tariff impacts, reflecting effective cost management and innovation.

Key takeaways

Order intake increased by 8%, marking the fourth consecutive quarter of growth, with strong momentum in North America.
Comparable sales growth improved to 3% year-on-year, supported by solid demand in Personal Health and Connected Care.
Adjusted EBITDA margin rose by 50 basis points to 12.3%, showcasing the effectiveness of productivity initiatives.
The company reiterated its full-year comparable sales growth outlook of 1% to 3%, with a projected adjusted EBITDA margin expected at the upper end of the 11.3% to 11.8% range.
Free cash flow guidance remains stable at between EUR 0.2 billion and EUR 0.4 billion for the full year.

View recap

CPI Card Group Inc.

PMTS Q3 2025

Reported: 2025-11-04

CPI Card Group reported a solid third quarter with an 11% increase in sales despite a 7% decline in adjusted EBITDA, primarily driven by a shift in product mix and tariff impacts. The company is focused on strategic initiatives to counter margin pressures while anticipating strong growth in the fourth quarter.

Key takeaways

Strong performance in Software-as-a-Service instant issuance and ongoing success with Arroweye contributed to Q3 sales growth.
Adjusted EBITDA faced a 7% decline due to unfavorable sales mix and tariff expenses, prompting a revised full-year guidance for adjusted EBITDA growth to be flat to low single-digit.
The new Indiana facility is operational, expected to enhance efficiencies and production capabilities moving into 2026.
CPI is experiencing growth in its digital solutions, particularly with new verticals in the instant issuance space, contributing to long-term growth expectations.
The company has entered a strategic partnership with Karta, enhancing its offerings in closed-loop prepaid solutions with advanced fraud prevention technologies.

View recap

PostNL N.V.

PNL.AS Q3 2025

Reported: 2025-11-04

PostNL's Q3 2025 results reflect a challenging environment, with a marked decline in Mail operations overshadowing slight volume growth in Parcels. The company remains focused on its strategic Breakthrough 2028 program, which aims for significant revenue and EBIT growth by 2028.

Key takeaways

Revenue reached EUR 762 million, slightly above the previous year, but normalized EBIT stood at a negative EUR 21 million, aligning with expectations.
Mail volumes declined by nearly 5%, largely due to ongoing substitution trends, despite contributions from election mail.
Cost savings measures are on track, with emission-free last-mile deliveries increasing to 33%, reflecting a commitment to sustainability.
The strategic division of the Parcels segment into e-commerce and platforms is set for 2026, focusing on growth and operational efficiency.
Free cash flow for the quarter was reported at a negative EUR 18 million, though year-to-date figures remain stable compared to last year.

View recap

Chicago Atlantic Real Estate Finance Inc. Common Stock

REFI Q3 2025

Reported: 2025-11-04

Chicago Atlantic Real Estate Finance reported resilient performance amid market volatility, showcasing a disciplined approach to capital deployment and a strong cannabis loan pipeline despite challenges in the private credit environment.

Key takeaways

Loan portfolio totaled approximately $400 million with a weighted average yield to maturity of 16.5%.
Gross originations of $39.5 million were offset by $62.7 million in unscheduled principal repayments.
The company maintained a robust structure, with only 14% of the portfolio exposed to further interest rate declines due to protective rate floors.
Management's recent share repurchases reflect confidence in the underlying value and strategy of the company.
Total leverage decreased to 33% of book equity, providing enhanced liquidity and a favorable risk-return profile.

View recap

RingCentral, Inc.

RNG Q3 2025

Reported: 2025-11-04

RingCentral delivered solid performance in Q3 2025, with subscription revenue growing 6% year-over-year, driven by a successful integration of AI-driven products and a robust core voice platform.

Key takeaways

Subscription revenue increased 6% YOY, reflecting sustained momentum in core business and AI-led solutions.
AI-driven ARR is showing strong double-digit growth, contributing significantly to overall annual recurring revenue.
Over half of RingCentral's revenue comes from key verticals such as healthcare and financial services, with voice usage on the platform growing in double digits.
New product offerings, including RingCX and various AI agents (AIR, AVA, ACE), are gaining traction and expected to surpass $100 million in ARR by the end of 2025.
Expanded partnerships, particularly with AT&T, are enhancing market reach and accelerating adoption of AI-led products.

View recap

Sealed Air Corporation

SEE Q3 2025

Reported: 2025-11-04

Sealed Air delivered a solid third quarter in 2025, showcasing resilience amid challenging macroeconomic conditions, with progress seen in both the Protective and Food segments despite ongoing market pressure.

Key takeaways

Protective segment showed sequential sales growth, driven by an increase in material volumes for the first time since 2021, while ongoing transformational efforts are yielding positive results.
North American operations have stabilized, landing multiple competitive wins at national accounts, indicating improved engagement with larger customers.
Food segment performance held steady as consumer preferences shifted towards value grocery and pre-packaged solutions, allowing the company to adjust its product mix effectively.
Continued focus on network optimization and R&D improvements is expected to enhance unit economics and accelerate product development timelines.
Overall, Sealed Air is prioritizing cost control and productivity enhancements to navigate the uncertain consumer landscape.

View recap

Shoals Technologies Group, Inc.

SHLS Q3 2025

Reported: 2025-11-04

Shoals Technologies Group reported record Q3 revenue of $135.8 million, reflecting a robust 32.9% year-over-year growth, driven by a strong backlog and a positive demand environment for solar energy.

Key takeaways

New orders totaled $185.4 million, resulting in a backlog of $720.9 million, a 21% year-over-year increase.
Adjusted EBITDA reached $32 million, or 23.5% of revenue, indicating effective cost management and strong operational performance.
The company slightly increased its full-year revenue growth forecast to 17%-20%, signaling sustained momentum into 2026.

View recap

Shopify Inc.

SHOP Q3 2025

Reported: 2025-11-04

Shopify reported a robust Q3 2025 with 32% growth in both GMV and revenue, while maintaining an impressive 18% free cash flow margin, showcasing its ability to balance growth and profitability.

Key takeaways

Achieved 32% year-over-year growth in Gross Merchandise Volume (GMV) and revenue.
Maintained consistent free cash flow margins, up to 18% from previous quarters.
Introduced advanced AI tools to enhance shopping experiences, positioning Shopify as a leader in agentic commerce.
Focused on international expansion and offline B2B channels to capture new market opportunities.
Continuous entrepreneurial growth, with a new sale occurring on Shopify every 26 seconds.

View recap

Sundial Growers Inc.

SNDL Q3 2025

Reported: 2025-11-04

SNDL reported a strong third quarter of 2025, achieving record free cash flow and positive cumulative free cash flow for the first nine months of the year, despite facing a reported operating loss due to noncash items.

Key takeaways

Net revenue reached $244 million, a 3.1% year-over-year increase driven primarily by the Cannabis segment.
Free cash flow stood at $16.7 million for Q3, marking a $7.5 million improvement compared to the previous year, and bringing year-to-date total to $7.7 million.
Operating income was impacted by $11.9 million in noncash adjustments, including share-based compensation related to stock price increases.
Continued investment in growth, with the acquisition of 32 cannabis stores pending regulatory approval and plans to open several new retail locations in Q4.
Improvements in gross profit margins were countered by noncash inventory-related adjustments, highlighting operational challenges in the Cannabis Operations segment.

View recap

Sumitomo Chemical Company, Limited

SOMMY Q2 2025

Reported: 2025-11-04

Sumitomo Chemical’s Q2 fiscal 2025 results show notable improvements in core operating income and net profits, driven by strong sales at Sumitomo Pharma and favorable foreign exchange conditions.

Key takeaways

Core operating income surged to JPY 108.7 billion, up JPY 79.2 billion year-over-year, reflecting robust performance in Essential & Green Materials and Sumitomo Pharma.
Net income attributable to owners of the parent reached JPY 39.7 billion, a substantial increase of JPY 46.2 billion compared to the prior year.
Sales revenue fell to JPY 1,954 billion, down JPY 146 billion year-on-year, primarily impacted by decreased volumes across most segments.
Strong performance in Sumitomo Pharma was underscored by sales gains from ORGOVYX and reduced selling expenses.
The company improved its cash position, with equity rising to JPY 1,179.6 billion but experienced a drop in free cash flow to JPY 41 billion, reflecting increased working capital demands.

View recap

SOPHiA GENETICS SA Ordinary Shares

SOPH Q3 2025

Reported: 2025-11-04

SOPHiA GENETICS delivered a strong Q3 2025 performance with 23% year-over-year revenue growth, driven by record new customer signings and sustained momentum in the U.S. market, prompting the company to raise its revenue guidance for the year.

Key takeaways

New customer signings reached 31 in Q3, bringing the total for 2025 to 94, surpassing last year’s total.
U.S. revenue grew 30% year-over-year as new strategic partnerships with major health systems were established.
The launch and global adoption of the liquid biopsy application MSK-ACCESS has seen more than 60 customers signed, with significant backing from AstraZeneca for its deployment.
SOPHiA's innovative Digital Twins technology aims to enhance treatment decision-making by leveraging multimodal data for oncology.
Full-year revenue guidance is now set between $75 million and $77 million, reflecting strong business momentum.

View recap

Simon Property Group, Inc.

SPG Q3 2025

Reported: 2025-11-04

Simon Property Group reported solid third-quarter results, driven by higher occupancy rates, strong retail sales, and a successful acquisition of Taubman Realty Group, enhancing its growth potential.

Key takeaways

Third-quarter FFO increased to $3.22 per share, reflecting 5.6% year-over-year growth largely driven by robust lease income.
Occupancy reached 96.4% for Malls and Premium Outlets, with a sequential increase of 40 basis points, supported by strong retailer demand.
Completed acquisition of the remaining 12% interest in Taubman Realty Group, projected to enhance operational efficiencies and increase NOI by 50 basis points in the future.
Liquidity remains strong with $9.5 billion available, backed by successful capital market activities including a $1.5 billion senior note offering.
Full-year 2025 FFO guidance increased to $12.60 - $12.70 per share, a clear signal of confidence in continued operational performance.

View recap

Sphere Entertainment Co.

SPHR Q3 2025

Reported: 2025-11-04

Sphere Entertainment reported strong Q3 2025 results with a 37% year-over-year increase in segment revenues, driven by the successful launch of the "Wizard of Oz" experience, which has sold over 1 million tickets.

Key takeaways

Total company revenues reached $262.5 million with adjusted operating income of $36.4 million.
The Sphere segment generated $174.1 million in revenue, largely due to heightened demand for the "Wizard of Oz," contributing over $130 million in ticket sales shortly after its opening.
Significant reduction in SG&A expenses, down $12.3 million from the previous year, underscoring effective cost management initiatives.
Sphere's net debt stands at approximately $205 million with $329 million in cash reserves, indicating a strong liquidity position.
Ongoing expansion discussions for new Sphere venues internationally, with designs for seating capacities ranging from 3,000 to 18,000.

View recap

Sequans Communications S.A.

SQNS Q3 2025

Reported: 2025-11-04

Sequans Communications reported a strategic reduction of 50% in its convertible debt through tactical adjustments in its Bitcoin treasury, positioning the company for improved financial flexibility and future growth.

Key takeaways

Successfully reduced debt-to-NAV ratio to approximately 35%, enhancing leverage for future financing.
Established ADS buyback program, prioritizing repurchases as shares trade at a discount to intrinsic value.
Healthy IoT business pipeline with $550 million potential revenue over three years, including 6 new projects and a 20% increase in design wins.
Anticipating revenue-generating transitions for design win projects, with 45% expected to be in production by end of Q4 2025.
Reinforcement of commitment to Bitcoin treasury strategy while exploring additional opportunities to unlock shareholder value.

View recap

Sarepta Therapeutics, Inc.

SRPT Q3 2025

Reported: 2025-11-04

Sarepta continued to progress toward potential traditional approval for VYONDYS and AMONDYS, completing its confirmatory study while demonstrating a significant, albeit non-statistically significant, treatment benefit in slowing disease progression in Duchenne muscular dystrophy patients.

Key takeaways

The confirmatory study completed for VYONDYS and AMONDYS showed a meaningful treatment benefit, with a 30% slowing of disease progression when excluding COVID-19 affected participants.
Despite missing statistical significance, subgroup analyses indicated strong benefits for treatment among likely progressors.
Continued high patient compliance rates above 90%, despite the demanding infusion protocol, underscored the perceived value of the therapies.
Sarepta plans to engage with the FDA to discuss transitioning from accelerated to traditional approval based on the totality of available evidence.

View recap

Neuronetics, Inc.

STIM Q3 2025

Reported: 2025-11-04

Neuronetics reported a strong Q3 2025, with total revenue increasing 11% year-over-year, driven by robust performance in Greenbrook clinics and effective integration strategies.

Key takeaways

Total revenue reached $37.3 million, bolstered by a 25% increase in revenue at Greenbrook clinics.
System sales for NeuroStar were solid, with 40 units shipped and consistent average selling prices exceeding targets.
Treatment session utilization for NeuroStar grew by 11% compared to the prior year, indicating strong demand for its services.
The underway integration of the Greenbrook business and expansion of the SPRAVATO rollout is poised to enhance operational efficiency and profitability.
The company strategically optimized its RAM program, successfully scheduling over 350 physician meetings to drive referrals, resulting in over 2,200 patients referred in Q3.

View recap

Sterling Construction Company, Inc.

STRL Q3 2025

Reported: 2025-11-04

Sterling Infrastructure delivered robust third-quarter results, highlighted by a 32% revenue growth driven by a strong performance in E-Infrastructure Solutions, and a significant 64% year-over-year increase in backlog.

Key takeaways

Revenue rose to $700 million, propelled by a 58% increase in E-Infrastructure Solutions, with 42% of this growth organic.
Adjusted EPS grew 58% to $3.48, and adjusted EBITDA was up 47% at $156 million, aided by expanded gross margins of 24.7%.
Backlog reached $2.6 billion, increasing 64% year-over-year, excluding CEC, with a strong E-Infrastructure backlog growth of 97%.
CEC acquisition enhanced service portfolio and contributed $41.4 million in revenue for September.
Strong operating cash flow of $84 million reflects continued financial health despite challenges in the residential market.

View recap

Stanley Black & Decker, Inc.

SWK Q3 2025

Reported: 2025-11-04

Stanley Black & Decker reported strong progress in its strategic transformation during Q3 2025, with a focus on brand activation and operational excellence positioned to drive future growth.

Key takeaways

On track to achieve $2 billion in cost reductions by year-end 2025 while targeting a 35% adjusted gross margin.
Successfully implemented a brand-led marketing strategy, enhancing engagement with end users through dedicated trade specialists and innovation-focused initiatives.
Positive momentum in key brands: DEWALT continues to lead in organic growth, supported by initiatives to train and upskill tradespeople.
Operational improvements are yielding gains in productivity, expected to contribute to margin expansion and fund future growth investments.

View recap

Tactile Systems Technology, Inc.

TCMD Q3 2025

Reported: 2025-11-04

Tactile Medical reported robust third-quarter results with total revenue of $85.8 million, achieving a 17% year-over-year increase, driven by significant growth in both lymphedema and airway clearance segments. The company raised its full-year revenue guidance amid strong operational progress and an expanded field sales team.

Key takeaways

Total revenue grew 17% year-over-year to $85.8 million; lymphedema revenue up 11% and airway clearance revenue surged 71%.
Adjusted EBITDA rose 34% year-over-year to $14.4 million, reflecting improved profitability.
Strengthened field sales organization achieved record headcount of 329 reps, supporting market demand effectively.
Significant growth in the Medicare payer channel, up 130% year-over-year, helped drive recovery in lymphedema sales.
Updated full-year revenue guidance raised to $317-$321 million, indicating an 8% to 10% growth outlook.

View recap

TIM S.A.

TIMB Q3 2025

Reported: 2025-11-04

TIM S.A. reported robust Q3 2025 results, with net income surging 42.2% year-over-year, driven by strong service revenue growth and effective cost management.

Key takeaways

Service revenues increased 5.2% year-over-year, bolstered by a strong mobile segment and postpaid expansion.
EBITDA rose 6.7% year-over-year, achieving a margin of 50.3%, reflecting disciplined CapEx and operational efficiency.
The company executed BRL 1.8 billion in interest on capital and repurchased BRL 369 million in shares, underscoring its commitment to shareholder returns.
The successful TIM Smart Mining solution partnership with Vale positions TIM to enhance its B2B offerings and diversify revenue streams.
Continued investments in network modernization led to superior connectivity quality, with 5G now available in 1,000 Brazilian cities, driving customer satisfaction and retention.

View recap

Uber Technologies, Inc.

UBER Q3 2025

Reported: 2025-11-04

Uber's Q3 2025 exhibited robust growth, with a 22% increase in trips and significant advancements in gross bookings and EBITDA, driven by strategic innovations and expanded services.

Key takeaways

Mobility trips surged 21%, surpassing expectations alongside a record growth in gross bookings, up 21%.
Adjusted EBITDA reached new heights, supporting continued investment in customer-centric innovations and operational efficiency.
Strategic focus areas include deepening cross-platform engagement, autonomous vehicle integration, and expanding local commerce opportunities, positioning Uber for long-term growth.
An impressive 130 million trips coincided with Halloween, generating over $2 billion in bookings, highlighting peak consumer engagement.
Anticipating continued momentum, Uber targets high teens gross bookings growth and low to mid-30s EBITDA growth for Q4 2025.

View recap

Upwork Inc.

UPWK Q3 2025

Reported: 2025-11-04

Upwork's third quarter of 2025 marked a significant turning point, achieving record revenue of $201.7 million and a 2% year-over-year growth in gross services volume (GSV) as the company capitalizes on its AI-driven marketplace strategy.

Key takeaways

Revenue surpassed $200 million for the first time, with GAAP net income reaching $29.3 million.
Adjusted EBITDA hit an all-time high of $59.6 million, translating to a margin of 29.6%.
AI-related project activity on the platform surged, with GSV from AI work up 53% year-over-year.
Adoption of Upwork Business Plus grew 36% quarter-over-quarter, demonstrating strong demand among SMBs.
The launch of Lifted aims to tap into the $650 billion contingent work market, with robust early interest from clients.

View recap

Vital Farms, Inc.

VITL Q3 2025

Reported: 2025-11-04

Vital Farms reported a record net revenue of $198.9 million in Q3 2025, a 37.2% increase year-over-year, alongside a substantial 81.3% rise in adjusted EBITDA, signaling robust operational efficiency and market demand.

Key takeaways

Gross margin improved to 37.7%, surpassing the long-term target of 35%.
Net income surged 121% to $16.4 million, reflecting strong operating profit growth.
The company expanded its network by adding 75 family farms, totaling 575, enhancing egg supply capabilities.
Another 2% increase in brand awareness, now at 33%, highlighting effective marketing strategies.
Full-year guidance for fiscal 2025 has been raised due to strong performance and operational execution.

View recap

Vornado Realty Trust

VNO Q3 2025

Reported: 2025-11-04

Vornado Realty Trust delivered a strong performance in Q3 2025, leveraging robust tenant demand and effective leasing strategies to achieve industry-leading results amidst a revitalizing New York City office market.

Key takeaways

Vornado's office leasing volume reached 3.7 million square feet in the first nine months, marking the highest in over a decade and featuring average starting rents of $99 per square foot.
Q3 demonstrated a remarkable 15.7% GAAP and 10.4% cash mark-to-market increase, with an average lease term exceeding 12 years.
PENN 2 achieved 78% occupancy and is on track to exceed year-end guidance, contributing to a projected incremental cash yield increase above 10.2%.
With a net debt-to-EBITDA ratio of 7.3x and liquidity of $2.6 billion, Vornado maintains a strong balance sheet amidst a competitive real estate landscape.

View recap

Vertex Pharmaceuticals Incorporated

VRTX Q3 2025

Reported: 2025-11-04

Vertex Pharmaceuticals reported a strong Q3 2025 performance with revenues of $3.08 billion, driven by robust growth in cystic fibrosis treatments and advancements in its renal disease pipeline.

Key takeaways

Achieved revenue of $3.08 billion, representing double-digit growth year-over-year.
Continued strong uptake of ALYFTREK, qualifying 95% of CF patients for treatment, with significant clinical improvements reported.
Progressing towards regulatory submissions for TRIKAFTA for ages 1-2, demonstrating unprecedented reductions in sweat chloride levels.
Promising developments in the kidney portfolio, including initiation of Phase II studies for VX-407 and inaxaplin targeting serious renal diseases.
Successful Phase IV trials for JOURNAVX in acute pain management indicate significant reductions in opioid use post-surgery.

View recap

Stem, Inc.

VSTM Q3 2025

Reported: 2025-11-04

Verastem Oncology reported strong Q3 results with net product revenue of $11.2 million from the AVMAPKI FAKZYNJA CO-PACK launch, indicating robust adoption by healthcare providers and effective commercial strategies.

Key takeaways

Net product revenue for Q3 2025 was $11.2 million, exceeding expectations fueled by strong physician engagement and patient initiation.
The company successfully achieved its three launch objectives: enhancing physician outreach, supporting patient access, and streamlining reimbursement processes.
Over 60% of prescriptions are generated by gynecological oncologists, with a substantial presence in both academic and community practices.
Enrollment in clinical trials for AVMAPKI FAKZYNJA CO-PACK and VS-7375 programs remains on track, with positive safety and tolerability data reported.
High engagement levels with healthcare providers and effective outreach to patients showcase the brand's strength and market penetration.

View recap

Waters Corporation

WAT Q3 2025

Reported: 2025-11-04

Waters Corporation posted robust third quarter results with sales and earnings exceeding expectations, driven by innovative product growth and strategic advancements in high-demand areas.

Key takeaways

Q3 sales increased 8% year-over-year, with instruments growing 6%, particularly in the LC-MS portfolio.
Non-GAAP EPS rose 16% to $3.40, surpassing the guidance midpoint by $0.20.
GLP-1 testing revenue more than doubled, showing strong traction in development and manufacturing sectors.
Instrument sales recorded their largest non-COVID third quarter ramp, driven by significant customer adoption and replacement cycles.
Continued strength in international markets, particularly in Japan and India, contributed to overall sales and service growth.

View recap

Wingstop Inc.

WING Q3 2025

Reported: 2025-11-04

Wingstop Inc. reported a mixed Fiscal Q3 2025, with robust restaurant expansion and technology upgrades overshadowed by a temporary decline in same-store sales. Management remains optimistic about a return to growth through strategic investments.

Key takeaways

Opened 369 new restaurants in 2025, achieving a 19% unit growth rate, nearing 3,000 global locations.
Implemented the new kitchen operating platform in over 2,000 restaurants, improving service speed by over 50% and enhancing guest satisfaction scores.
Experienced a 5.6% decline in same-store sales for Q3, attributed to broader industry softness.
Launched a new marketing campaign aimed at increasing brand awareness and engagement, targeting new consumer segments.
Positioned to launch a loyalty program leveraging a digital platform with over 60 million users, enhancing customer retention and sales potential.

View recap

Xenon Pharmaceuticals Inc.

XENE Q3 2025

Reported: 2025-11-04

Xenon Pharmaceuticals continues to demonstrate strong momentum, with successful patient randomization in its Phase III X-TOLE2 study for azetukalner, while also expanding its therapeutic focus beyond epilepsy.

Key takeaways

Completed successful randomization of 380 patients for the Phase III X-TOLE2 trial, exceeding initial targets.
Top line data readout expected in early 2026, maintaining high confidence in positive outcomes based on historical study results.
Evaluating broader therapeutic applications for azetukalner in major depressive disorder and bipolar depression, supported by robust preclinical and clinical evidence.
Advancing early-stage pipeline with promising candidates in ion channel programs, signaling growth potential beyond current epilepsy focus.

View recap

Xometry Inc. Class A Common Stock

XMTR Q3 2025

Reported: 2025-11-04

Xometry reported a record Q3 2025, with a 28% year-over-year increase in revenue to $181 million, driven by a 31% acceleration in marketplace growth and significant market share gains amidst a contracting manufacturing sector.

Key takeaways

Marketplace gross margin improved by 210 basis points year-over-year to 35.7%, contributing to a 40% increase in marketplace gross profit.
The company's expansion into new enterprise solutions, including an auto-quoting feature for injection molding, enhances customer engagement and operational efficiency.
Xometry's active supplier network grew to over 4,500, supporting supply chain resilience and agility through diversified sourcing options.
The firm is raising its full-year marketplace growth outlook, reflecting strong momentum heading into Q4 2025.

View recap

Yum! Brands, Inc.

YUM Q3 2025

Reported: 2025-11-04

Yum! Brands reported a robust Q3 with system sales increasing by 5% and core operating profit rising 7%, signaling effective management transitions and strong brand performance across key segments.

Key takeaways

Taco Bell achieved impressive 7% same-store sales growth, enhancing its competitive edge in the market.
KFC demonstrated a 14% increase in core operating profit, driven by 6% unit growth and solid performance in international markets.
The company is evaluating strategic options for the Pizza Hut brand, aiming to unlock greater value and enhance franchise partnerships.
Yum! announced plans to acquire 128 Taco Bell restaurants, set to boost profitability and expand regional leadership.
Leadership changes aim to strengthen focus on consumer engagement and operational agility across all brands.

View recap

China Holdings, Inc.

YUMC Q3 2025

Reported: 2025-11-04

Yum China delivered a strong third quarter for 2025, marked by an 8% increase in operating profit and accelerated store expansion, reflecting robust consumer demand across its brands.

Key takeaways

System sales rose 4% year-over-year, with same-store sales achieving growth for the second consecutive quarter.
Operating profit reached a record $400 million, demonstrating improved restaurant margins of 17.3%.
KFC opened a record 402 net new stores, contributing to a total of over 12,640 locations, while Pizza Hut surpassed 4,000 stores.
Delivery sales increased to 51% of total sales, bolstered by innovative menu offerings and effective promotional strategies.
Continued focus on menu innovation and entry-level pricing positions Yum China to capture a broader consumer base, especially in lower-tier cities.

View recap

Earnings Recaps

BioNTech SE

Adeia Inc. Common Stock

Archer-Daniels-Midland Company

ADT Inc.

Armada Hoffler Properties, Inc.

Aker ASA

Ameresco, Inc.

Apollo Global Management, Inc.

Biodesix, Inc.

Hugo Boss AG

Black Stone Minerals, L.P.

BWX Technologies, Inc.

CompoSecure Inc. Class A Common Stock

Costamare Inc.

Castle Biosciences, Inc.

EverQuote, Inc.

Eve Holding, Inc.

Evonik Industries AG

Exact Sciences Corporation

Exelon Corporation

TIS Inc.

Great Lakes Dredge & Dock Corporation

Gladstone Commercial Corporation

Grab Holdings Limited Class A Ordinary Shares

The Goodyear Tire & Rubber Company

ZoomInfo Technologies Inc.

Halozyme Therapeutics, Inc.

Hims & Hers Health, Inc.

Hertz Global Holdings Inc Common Stock

IAC/InterActiveCorp

Ichor Holdings, Ltd.

Gartner, Inc.

Kosmos Energy Ltd.

Lattice Semiconductor Corporation

Marriott International, Inc.

Medifast, Inc.

AG Mortgage Investment Trust, Inc.

MPLX LP

PLAYSTUDIOS Inc. Class A Common Stock

National Retail Properties, Inc.

Nuvation Bio Inc.

Navitas Semiconductor Corporation Common Stock

Realty Income Corporation

Offerpad Solutions Inc. Class A Common Stock

Paymentus Holdings, Inc.

The Progressive Corporation

Koninklijke Philips N.V.

CPI Card Group Inc.

PostNL N.V.

Chicago Atlantic Real Estate Finance Inc. Common Stock

RingCentral, Inc.

Sealed Air Corporation

Shoals Technologies Group, Inc.

Shopify Inc.

Sundial Growers Inc.

Sumitomo Chemical Company, Limited

SOPHiA GENETICS SA Ordinary Shares

Simon Property Group, Inc.

Sphere Entertainment Co.

Sequans Communications S.A.

Sarepta Therapeutics, Inc.

Neuronetics, Inc.

Sterling Construction Company, Inc.

Stanley Black & Decker, Inc.

Tactile Systems Technology, Inc.

TIM S.A.

Uber Technologies, Inc.

Upwork Inc.

Vital Farms, Inc.

Vornado Realty Trust

Vertex Pharmaceuticals Incorporated

Stem, Inc.

Waters Corporation

Wingstop Inc.

Xenon Pharmaceuticals Inc.

Xometry Inc. Class A Common Stock

Yum! Brands, Inc.

China Holdings, Inc.

Community